FIMBRION THERAPEUTICS
FIMBRION THERAPEUTICS
Industry:
Health Care Life Science Therapeutics
Founded:
2012-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.fimbrion.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Diamond Therapeutics
Diamond Therapeutics is a psychedelic drug development company.
Mannheim Pharma & Diagnostics GmbH
Mannheim Pharma & Diagnostics GmbH is a life science company.
Mimir Insights
Mimir Insights a life science data company.
Official Site Inspections
http://www.fimbrion.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Fimbrion Therapeutics"
Leadership Team โ Fimbrion Therapeutics
Fimbrion Therapeutics, Inc. is a life sciences company based in St. Louis, MO founded in 2012 from intellectual property licensed from Washington University. Fimbrionโs mission is to discover, develop, and commercialize antimicrobial โฆSee details»
Mission โ Fimbrion Therapeutics
Fimbrionโs initial focus is the development and commercialization of an orally active drug to prevent and treat urinary tract infections (UTIs). Options for treating bacterial infections, โฆSee details»
Fimbrion Therapeutics - Crunchbase Company Profile โฆ
Fimbrion Therapeutics is located in St Louis, Missouri, United States. Who are Fimbrion Therapeutics 's competitors? Alternatives and possible competitors to Fimbrion Therapeutics may include Oncodrone , Diamond Therapeutics , and โฆSee details»
Fimbrion Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Fimbrion Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Disease Domain:Infectious Diseases, Technology ...See details»
Fimbrion Therapeutics, Inc. | LinkedIn
Fimbrion Therapeutics, Inc. Pharmaceutical Manufacturing St Louis, Missouri 666 followers Antibiotic-sparing approaches to fight acute and resistant infections caused by bacteria and โฆSee details»
Fimbrion Company Profile 2024: Valuation, Funding
Fimbrion has 6 total employees. What industry is Fimbrion in? Fimbrionโs primary industry is Drug Discovery. Is Fimbrion a private or public company? Fimbrion is a Private company. What is Fimbrionโs current revenue? The current revenue โฆSee details»
Fimbrion Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Fimbrion Therapeutics, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Fimbrion Therapeutics - Contacts, Employees, Board Members
Fimbrion Therapeutics is a life sciences company. Unlock even more features with Crunchbase ProSee details»
Fimbrion Therapeutics - Overview, News & Competitors - ZoomInfo
Fimbrion Therapeutics contact info: Phone number: (860) 938-2315 Website: www.fimbrion.com What does Fimbrion Therapeutics do? The mission of Fimbrion Therapeutics, Inc. is to โฆSee details»
Fimbrion and GSK Identify Novel, Antibiotic-Sparing โฆ
Dec 6, 2018 /PRNewswire/ -- Fimbrion Therapeutics, Inc. announced that under its joint research collaboration with GSK, ... As a unit within GSK's research and development organization, DPAc is dedicated to ...See details»
Thienopyrimidine Inhibitors of QcrB as Novel Drugs for Tuberculosis
Fimbrion Founders & Scientific Advisory Team Scott J. Hultgren, PhD James W. Janetka, PhD Thomas Hooton, MD Funding Sources NIH/NIAID SBIR R43/44 AI149833 BioSTL โฆSee details»
Board of Directors โ Fimbrion Therapeutics
Fimbrion Therapeutics, Inc. is a life sciences company based in St. Louis, MO founded in 2012 from intellectual property licensed from Washington University. Fimbrionโs mission is to โฆSee details»
GSK partners with startup to develop antibiotic alternative
Oct 25, 2016 Fimbrion Therapeutics has been around since 2012, but itโs divulged very little about its research or its backers thus far. The St. | A St. Louis, MO-based preclinical startup โฆSee details»
Fimbrion therapeutics, inc. Reviews | Read Client Reviews of โฆ
Fimbrion therapeutics, inc. Review Reviews 11. 3.9See details»
GSK links with Fimbrion to develop UTI drug - PharmaTimes
Oct 26, 2016 GlaxoSmithKline has formed a partnership with US biotech Fimbrion Therapeutics to develop a first-in-class small molecule drug for the treatment and prevention of urinary tract โฆSee details»
GSK and Fimbrion partner to develop molecule drug for UTIs
Oct 26, 2016 Fimbrion Therapeutics president Dr Hultgren said: "We are excited for this strategic relationship and partnership with GSK enabling the development of our first drug candidate. โฆSee details»
Pipeline โ Fimbrion Therapeutics
Board of Directors. FCOI Policy. ContactSee details»
Urinary Tract Infections โ Fimbrion Therapeutics
Fimbrion will continue to further develop its platform technology and pipeline with additional narrow-spectrum antimicrobial strategies to combat UTIs and other bacterial infections that โฆSee details»
Tuberculosis - Fimbrion Therapeutics
Tuberculosis Tuberculosis (TB) is caused by infection with the bacterium Mycobacteria tuberculosis (Mtb) and is the leading cause of mortality in the world for a single infectious โฆSee details»